Press release
Deadline on March 19th coming up in Lawsuit for certain Investors in BioVie Inc. (NASDAQ: BIVI)
A Deadline is coming up on March 19, 2024 in the lawsuit for certain investors in BioVie Inc. (NASDAQ: BIVI).
Investors who purchased shares of BioVie Inc. (NASDAQ: BIVI) have certain options and there are strict and short deadlines running. Deadline: March 19, 2024. NASDAQ: BIVI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. . District Court for the District of Nevada the plaintiff alleges on behalf of purchasers of BioVie Inc. (NASDAQ: BIVI) common shares between August 5, 2021 and November 29, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 5, 2021 and November 29, 2023, the Defendants misled investors by failing to disclose that BioVie was not conducting proper oversight of its Phase 3 clinical trial, that the COVID-19 pandemic significantly and negatively impacted the Company's ability to adequately conduct proper oversight of the Phase 3 clinical trial, that due to lack of proper oversight and reliance on contract research organizations, the data from Defendants' Phase 3 clinical trial faced a greater risk of being unreliable and that the majority of patients would have to be excluded from the clinical trial, that, as a result of the significant exclusions from the trial results, the Phase 3 clinical trial would fail to meet its primary endpoints, and that statements about BioVie's business, operations, prospects, and compliance with current good clinical practices ("cGCP") were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of BioVie Inc. (NASDAQ: BIVI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on March 19th coming up in Lawsuit for certain Investors in BioVie Inc. (NASDAQ: BIVI) here
News-ID: 3436992 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc.
Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation…
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc.
Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: RXST…
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc.
Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for BioVie
Investigation announced for Long-Term Investors in shares of BioVie Inc. (NASDAQ …
An investigation was announced for current long-term investors in shares of BioVie Inc. (NASDAQ: BIVI) concerning potential breaches of fiduciary duties by certain directors and officers of BioVie Inc.
Investors who are current long term investors in BioVie Inc. (NASDAQ: BIVI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ:…
Lawsuit filed for Investors who lost money with shares of BioVie Inc. (NASDAQ: B …
An investor, who purchased shares of BioVie Inc. (NASDAQ: BIVI), filed a lawsuit over alleged violations of Federal Securities Laws by BioVie Inc. in connection with certain allegedly false and misleading statements.
If you purchased a significant amount of shares of BioVie Inc. (NASDAQ: BIVI) between August 5, 2021 and November 29, 2023, and / or if you purchased any NASDAQ: BIVI shares prior to August 2021 and continue to…
Malignant Ascites Treatment Market Future Business Opportunities 2021-2028 | Pha …
Malignant Ascites Treatment Market is growing rapidly with rising cases of cirrhosis and a high prevalence of cancer
Market Overview
Malignant ascites are a disease that affects the colon. It is caused by colon cancer which has spread to the intestinal lining of your stomach. It can also occur when cancer spreads into the liver. Those individuals with malignant ascites will have the following symptoms. Malignant Ascites can affect both the…
Hepatorenal Syndrome Market 2020 Brief Analysis || Leading Players - BioVie Inc. …
Global hepatorenal syndrome market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The rise in the market growth can be attributed to the factor such as prevailing cases of liver cirrhosis which mainly occurs due to the constriction of blood vessels providing nutrient supply to the kidneys, leading further to kidney dysfunction.
Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hepatorenal-syndrome-market
Few of the major competitors currently…
Global Ascites Treatment Market Research Report 2019-2025 | Key Vendors Like-Seq …
The global market status for Ascites Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Ascites Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Ascites Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,…
Ascites Treatment Market Analysis and Growth (2019-2025): by Key Companies Sequa …
The Global Ascites Treatment market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Ascites Treatment Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
